Market Overview
The MillTicket Crypto Coin, combines video games, cannabis, and NFT. The integration of the 3 markets with blockchain technology makes our Web3 game and coin a disruptive combination with enormous growth potential.
Video games are an ecosystem that has evolved by leaps and bounds in recent years, to the point of recreating parallel universes that allow users to interact online with other users around the world. A recent study reveals that at least 3.1 billion people out of the 8 billion inhabitants worldwide play video games, roughly 40% of the world's population. The Asian continent is at the forefront with 1.4 billion players. Europe ranks second with 668 million consumers. Followed by Latin America and North America with 383 and 261 million consumers respectively.
Blockchain technology is a public, shared and decentralized database that functions as a ledger where buying and selling operations or any other type of transaction are recorded. Broadly speaking, the benefits that blockchain offers to the video game industry are:
Ownership: For the first time in history, users can be the real owner of the game assets.
Digital exchange: Users have the opportunity to exchange game assets with other users in the ecosystem.
Translate to Real World: earnings from the game and The MillTicket Token will be accepted as payment by Cannabis brand Highly Edibles
Income: Users can generate revenue within the game ecosystem, not just developers.
Transparency: All blockchain game interactions can be referenced publicly.
During the 2021-2025 period, revenues are forecast to show a CAGR of 9.32%, resulting in revenues of $223 billion by 2025.
In addition, the new "Play to Earn" game mechanics are taking off right now and could cause a paradigm shift in the video game industry, just like "Free to Play" games did in the last few years. We firmly believe that this paradigm shift will result in most game studios being forced to offer "Play to Earn" incentives in order to meet the new market demands.
After a tough year for cannabis in 2020, 2021 brought along a rebound in development towards legalization, record-breaking sales of medical and adult-use cannabis as well as a massive influx of capital raises and M&A activity.
This report finds combined global sales of CBD, medical and adult-use cannabis topped US$37.4 billion in 2021, and could rise to US$105 billion by 2026
Overall, the industry is poised for a very exciting 2022, with the spread of legalisation being followed by strong industry growth. Benefits will be felt across justice, public health and the global economy.
- ADVERTISEMENT -
This report provides an overview of the key developments in international cannabis markets, and considers how they might develop in the near future. It also covers some of the most interesting and pertinent global trends in the industry.
The market sizing data package available provides country-level breakdowns of market sizing forecasts (2021-2026) for global cannabis markets, including medical, adult-use and CBD.
In addition, this package comes complete with the most comprehensive collection of real-world data available anywhere in the world: official data obtained from governments and health authorities globally, providing state/country-level metrics such as patient numbers, product source, and sales by product format.
Market Overview
Adult-use markets in the US and Canada remain the most important regions in the world for cannabis sales, but international markets including Germany, Israel and Australia will develop considerably over the next five years.
While the COVID-19 lockdown period saw record-breaking sales of cannabis in multiple regions, legislative developments have been interrupted, bringing delays in the development of cannabis market value across the globe.
As of late 2021 only Uruguay, Canada and a handful of states in the US have fully legalised cannabis for adult-use, but these will be joined by several international markets soon.
Mexico is primed for full legalisation of adult-use cannabis in 2022, while the Netherlands and Switzerland are preparing for their legal pilot trials. In November 2021, the coalition of parties set to lead the next German Government released a statement confirming that they have agreed to legalise the use and sales of adult-use cannabis in the country. This could signal the beginning of the largest cannabis industry outside of North America.
Medical cannabis and CBD are now legal, in some form, across most of North America, the European Union (EU) and the United Kingdom (UK), as well as Latin America; with Africa and Asia-Pacific lagging behind.
In December 2020, the United Nations (UN) recognised the potential medical utility and the safety of cannabis implicitly by removing it from Schedule IV of the Single Convention on Narcotic Drugs.
The large US multi-state-operators now rival the Canadian players for their size, and for the most part, exceed them in immediate financial performance.
This year, 2021, has been a significant one for cannabis Mergers and Acquisitions (M&A) for example; the acquisition of GW Pharmaceuticals by Jazz Pharmaceuticals for US$7.2 billion on 2 May, the merging of Aphria and Tilray, and the recent acquisition of Harvest Health and Recreation by Trulieve for US$ 2.2 billion.
Investor sentiment was shaken during the lockdown of 2020, and while stock prices are down, capital raises are now on the rise once again.
The balance of cannabis production is shifting away from the traditional strongholds of Canada and the Netherlands, with exports coming online from regions with warmer climates, cheaper land and labour; such as Latin America, the Mediterranean and Africa.
The most important import markets, including Germany and Israel, are currently engaging in domestic cultivation but it is yet to be seen how much future demand will be covered by this.
Ancillary services such as technology, professional services, extraction, distribution, packaging and construction are becoming increasingly important, with multi-billion dollar valuations for several cannabis technology companies.
Key Topics Covered:
Definition and Scope
Contents Overview
Key Global Trends
Medical Cannabis In A Rec-Legal World
Medical Cannabis Supply Chain
Cannabis Markets In A Post-Covid World
Cannabis Stocks
Market Sizing
Regional Overviews
Expert Interviews
Companies Mentioned
Always Pure Organics
Aphria
Aurora
Canopy Growth
Cantourage
CBDepot.eu
Cresco Labs
Cronos
Curaleaf
GW Pharmaceuticals
Jazz Pharmaceuticals
Linnea SA
Tilray
Trulieve
Village Farms
White Lion Holdings
For more information about this report visit https://www.researchandmarkets.com/r/ulrw7d
Last updated
